Additionally, eosinophilic cationic protein (ECP) correlates moderately with T2 cytokines, but it does not predict clinical response to dupilumab, a T2 inflammation inhibitor, in patients with CRSwNP [9, 10]. The gene discussed is RNASE3; the disease is chronic rhinosinusitis with nasal polyps.